5 Firms Sculpt SPAC Deal For $1B Tumor Treatment Developer
Alpha Tau Medical, which develops radiation therapy for solid tumors, will go public at an equity value of roughly $1 billion by merging with a health care-focused special purpose acquisition vehicle,...To view the full article, register now.
Already a subscriber? Click here to view full article